Cargando…
Usefulness of (18)F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature
Contrast-enhanced magnetic resonance imaging is currently the standard of care in the management of primary brain tumors, although certain limitations remain. Metabolic imaging has proven useful for an increasing number of indications in oncology over the past few years, most particularly (18)F-FDG...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541204/ https://www.ncbi.nlm.nih.gov/pubmed/33023662 http://dx.doi.org/10.1186/s40644-020-00348-5 |
_version_ | 1783591358492049408 |
---|---|
author | Somme, François Bender, Laura Namer, Izzie Jacques Noël, Georges Bund, Caroline |
author_facet | Somme, François Bender, Laura Namer, Izzie Jacques Noël, Georges Bund, Caroline |
author_sort | Somme, François |
collection | PubMed |
description | Contrast-enhanced magnetic resonance imaging is currently the standard of care in the management of primary brain tumors, although certain limitations remain. Metabolic imaging has proven useful for an increasing number of indications in oncology over the past few years, most particularly (18)F-FDG PET/CT. In neuro-oncology, (18)F-FDG was insufficient to clearly evaluate brain tumors. Amino-acid radiotracers such as (18)F-FDOPA were then evaluated in the management of brain diseases, notably tumoral diseases. Even though European guidelines on the use of amino-acid PET in gliomas have been published, it is crucial that future studies standardize acquisition and interpretation parameters. The aim of this article was to systematically review the potential effect of this metabolic imaging technique in numerous steps of the disease: primary and recurrence diagnosis, grading, local and systemic treatment assessment, and prognosis. A total of 41 articles were included and analyzed in this review. It appears that (18)F-FDOPA PET holds promise as an effective additional tool in the management of gliomas. More consistent prospective studies are still needed. |
format | Online Article Text |
id | pubmed-7541204 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-75412042020-10-08 Usefulness of (18)F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature Somme, François Bender, Laura Namer, Izzie Jacques Noël, Georges Bund, Caroline Cancer Imaging Review Contrast-enhanced magnetic resonance imaging is currently the standard of care in the management of primary brain tumors, although certain limitations remain. Metabolic imaging has proven useful for an increasing number of indications in oncology over the past few years, most particularly (18)F-FDG PET/CT. In neuro-oncology, (18)F-FDG was insufficient to clearly evaluate brain tumors. Amino-acid radiotracers such as (18)F-FDOPA were then evaluated in the management of brain diseases, notably tumoral diseases. Even though European guidelines on the use of amino-acid PET in gliomas have been published, it is crucial that future studies standardize acquisition and interpretation parameters. The aim of this article was to systematically review the potential effect of this metabolic imaging technique in numerous steps of the disease: primary and recurrence diagnosis, grading, local and systemic treatment assessment, and prognosis. A total of 41 articles were included and analyzed in this review. It appears that (18)F-FDOPA PET holds promise as an effective additional tool in the management of gliomas. More consistent prospective studies are still needed. BioMed Central 2020-10-06 /pmc/articles/PMC7541204/ /pubmed/33023662 http://dx.doi.org/10.1186/s40644-020-00348-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Somme, François Bender, Laura Namer, Izzie Jacques Noël, Georges Bund, Caroline Usefulness of (18)F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature |
title | Usefulness of (18)F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature |
title_full | Usefulness of (18)F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature |
title_fullStr | Usefulness of (18)F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature |
title_full_unstemmed | Usefulness of (18)F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature |
title_short | Usefulness of (18)F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature |
title_sort | usefulness of (18)f-fdopa pet for the management of primary brain tumors: a systematic review of the literature |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541204/ https://www.ncbi.nlm.nih.gov/pubmed/33023662 http://dx.doi.org/10.1186/s40644-020-00348-5 |
work_keys_str_mv | AT sommefrancois usefulnessof18ffdopapetforthemanagementofprimarybraintumorsasystematicreviewoftheliterature AT benderlaura usefulnessof18ffdopapetforthemanagementofprimarybraintumorsasystematicreviewoftheliterature AT namerizziejacques usefulnessof18ffdopapetforthemanagementofprimarybraintumorsasystematicreviewoftheliterature AT noelgeorges usefulnessof18ffdopapetforthemanagementofprimarybraintumorsasystematicreviewoftheliterature AT bundcaroline usefulnessof18ffdopapetforthemanagementofprimarybraintumorsasystematicreviewoftheliterature |